Servier Pharmaceuticals, LLC

États‑Unis d’Amérique


 
Quantité totale PI 102
Rang # Quantité totale PI 12 757
Note d'activité PI 2,8/5.0    83
Rang # Activité PI 8 384
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

79 12
0 0
11 0
0
 
Dernier brevet 2025 - Combination therapy for treating...
Premier brevet 2002 - Zinc phosphate-treated galvanize...
Dernière marque 2022 - VORAGLYNCE
Première marque 2016 - TIBSOVO

Industrie (Classification de Nice)

Derniers inventions, produits et services

2024 Invention Therapy for treating malignancies. Provided are methods and compositions for treating cancers in...
Invention Combination therapy for treating malignancies. Provided are methods and compositions for treating...
Invention Tablet compositions. Provided herein is a tablet comprising 2-methyl-1-[(4-[6-(trifluoromethyl)p...
Invention Methods of treating brain tumors using combination therapy. Provided are methods of treating a b...
P/S Anti-cancer preparations; Biological preparations for the treatment of and prevention of cancer; ...
2023 Invention Cocrystals, pharmaceutical compositions thereof, and methods of treatment involving same. Provid...
Invention Therapeutically active compounds and their methods of use. Provided are compounds useful for tre...
Invention Methods of use for trisubstituted benzotriazole derivatives. The present invention provides meth...
Invention Methods of treating enhancing brain tumors using combination therapy. Provided are methods for t...
Invention Methods of treating enhancing brain tumors using combination therapy. Provided are methods for tr...
Invention Therapeutically active compounds and their methods of use. Provided are methods of treating a ca...
Invention Methods and compositions for cell-proliferation-related disorders. Methods of treating and evalu...
2022 Invention Tablet compositions. Provided herein is a tablet comprising 2-methyl-1-[(4-[-6-(trifluoromethyl)...
Invention Cocrystals, pharmaceutical compositions thereof, and methods of treatment involving same. Provide...
Invention Inhibitors of cellular metabolic processes. The present disclosure provides MAT2A inhibitor compo...
Invention Therapeutically active compounds and their methods of use. Provided are compounds useful for trea...
2021 Invention New organic compounds. The present application provides MAT2A inhibitor compounds that are usefu...
Invention (heteo)aryl substituted pyrrolo-, pyrazolo- and triazolopyridazine derivates as mat2a inhibitors....
Invention Menin inhibitors and methods of use for treating cancer. The present disclosure provides compound...
Invention Use of a dhodh inhibitor compound in combination cancer therapy. Provided herein are method of tr...
Invention Solid state forms of an organic compound. Provided herein are various solid state forms, includin...
Invention Combination therapies for use in treating cancer. The compound of Formula (I), or pharmaceuticall...
Invention Use of a dhodh inhibitor compound in combination cancer therapy. Provided herein are method of t...
Invention Use of a dhodh inhibitor compound in combination cancer therapy. Provided herein a method of trea...
Invention Methods of treatment of malignancies. Provided are methods and compositions for treating cancers...
P/S Anti-cancer preparations, pharmaceutical products for the prevention and treatment of cancer, bio...
Invention Inhibitors of cyclin-dependent kinases and uses thereof. Provided are novel compounds of Formula ...
2020 Invention Combination therapy for treating malignancies. Provided are methods and compositions for treatin...
Invention Pharmaceutical compositions of therapeutically active compounds. Provided are compounds and pharm...
Invention Treatment of tumors incorporating mutant isocitrate dehydrogenase. The present invention provide...
Invention Therapeutically active compounds and their methods of use. Provided are methods of treating a can...
2019 Invention Crystalline and salt forms of an organic compound and pharmaceutical compositions thereof. ...
Invention Ivosidenib forms and pharmaceutical compositions. Provided are formulations of ivosidenib includ...
Invention Heterobicyclic inhibitors of mat2a and methods of use for treating cancer. The present disclosure...
Invention Methods of use for trisubstituted benzotriazole derivatives. 3 are as defined herein.
2018 Invention Methods of treating brain tumors using combination therapy. Provided are methods of treating a br...
2016 P/S anti-cancer preparations, pharmaceutical products for the prevention and treatment of cancer, bio...